224 related articles for article (PubMed ID: 29662002)
1. Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms.
Gong X; Smith JR; Swanson HM; Rubin LP
Molecules; 2018 Apr; 23(4):. PubMed ID: 29662002
[TBL] [Abstract][Full Text] [Related]
2. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide.
Knickle A; Fernando W; Greenshields AL; Rupasinghe HPV; Hoskin DW
Food Chem Toxicol; 2018 Aug; 118():154-167. PubMed ID: 29742465
[TBL] [Abstract][Full Text] [Related]
3. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
[TBL] [Abstract][Full Text] [Related]
4. Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways.
Wu YM; Chen ZJ; Jiang GM; Zhang KS; Liu Q; Liang SW; Zhou Y; Huang HB; Du J; Wang HS
Oncotarget; 2016 Mar; 7(11):12568-81. PubMed ID: 26871469
[TBL] [Abstract][Full Text] [Related]
5. Walsuronoid B induces mitochondrial and lysosomal dysfunction leading to apoptotic rather than autophagic cell death via ROS/p53 signaling pathways in liver cancer.
Geng YD; Zhang C; Lei JL; Yu P; Xia YZ; Zhang H; Yang L; Kong LY
Biochem Pharmacol; 2017 Oct; 142():71-86. PubMed ID: 28673807
[TBL] [Abstract][Full Text] [Related]
6. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of anethole and doxorubicin alleviates cell proliferation, cell cycle arrest, and ER stress and promotes ROS-mediated apoptosis in triple-negative breast cancer cells.
Arumugam P; Sampathkumar B; Perumalsamy H; Balusamy SR; Ramesh V; Sundaravadevel S
J Biochem Mol Toxicol; 2021 Dec; 35(12):e22928. PubMed ID: 34585488
[TBL] [Abstract][Full Text] [Related]
8. Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species.
Richards CE; Vellanki SH; Smith YE; Hopkins AM
Cell Oncol (Dordr); 2018 Feb; 41(1):35-46. PubMed ID: 29134467
[TBL] [Abstract][Full Text] [Related]
9. Novel Semi-Synthetic Cu (II)-Cardamonin Complex Exerts Potent Anticancer Activity against Triple-Negative Breast and Pancreatic Cancer Cells via Inhibition of the Akt Signaling Pathway.
Hossan MS; Break MKB; Bradshaw TD; Collins HM; Wiart C; Khoo TJ; Alafnan A
Molecules; 2021 Apr; 26(8):. PubMed ID: 33918814
[TBL] [Abstract][Full Text] [Related]
10. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.
Shrivastava S; Kulkarni P; Thummuri D; Jeengar MK; Naidu VG; Alvala M; Redddy GB; Ramakrishna S
Apoptosis; 2014 Jul; 19(7):1148-64. PubMed ID: 24729100
[TBL] [Abstract][Full Text] [Related]
12. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
13. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
14. Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species.
Roy A; Ahir M; Bhattacharya S; Parida PK; Adhikary A; Jana K; Ray M
Mol Carcinog; 2017 Sep; 56(9):2086-2103. PubMed ID: 28418078
[TBL] [Abstract][Full Text] [Related]
15. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer Cells.
Jinih M; Wang JH; Pfirrmann RW; O'Leary DP; Corrigan MA; Redmond HP
Anticancer Res; 2021 May; 41(5):2247-2256. PubMed ID: 33952451
[TBL] [Abstract][Full Text] [Related]
17. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
18. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
19. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
Sun ZL; Dong JL; Wu J
Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
[TBL] [Abstract][Full Text] [Related]
20. F1012-2 inhibits the growth of triple negative breast cancer through induction of cell cycle arrest, apoptosis, and autophagy.
Tian S; Chen Y; Yang B; Lou C; Zhu R; Zhao Y; Zhao H
Phytother Res; 2018 May; 32(5):908-922. PubMed ID: 29468753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
